Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Prospective, Randomized, Multi-Center Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin vs. Cefuroxime Monotherapy or Plus Oral Erythromycin for the Treatment of Chinese Hospitalized Patients With Community- Acquired Pneumonia

NCT00648726 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00648726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00648726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Prospective, Randomized, Multi-Center Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin vs. Cefuroxime Monotherapy or Plus Oral Erythromycin for the Treatment of Chinese Hospitalized Patients With Community- Acquired Pneumonia
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2003
Completion date
August 31, 2003
Enrollment
139 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia